Acrux Ltd (ASX:ACR) has been approved to begin U.S. commercialisation activities for its Nitroglycerin Ointment 0.4% targeting pain related to chronic anal fissures, with this marking the fourth ...
Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks Acrux Limited has announced the commercial launch of its Nitroglycerin 0.4% ointment in the US market through ...